ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

NUTX // Nutex Health Inc.

ANR <GO> NASDAQ RQD COCKPIT → CIK 0001479681 ↗
Consumer Discretionary • Business Services
$200.15 ▼ -9.95 (-4.74%)
MKT CAP: $1.44B • VOL: 120.1K
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8 SELL: 2
12M STREET TARGET RANGE IMPLIED: +14.0%
LOW
$168
MEDIAN
$224
MEAN
$228
HIGH
$272
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100 EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE NUTX TAPE
NUTX // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>) CURRENT 90D STREET CONSENSUS
INSTITUTION / ANALYST ACTION RATING TARGET PRIOR PT CALL DATE PX AT CALL RET SINCE CALL 1Y ACCURACY BS GRADE
Morgan Stanley Institutional
Equity Desk
REITERATE OUTPERFORM $242.18 $230.17 2025-02-14 $182.14 +9.9% 78% A
Goldman Sachs Global Research
Sector Coverage
TARGET REV STRONG BUY $252.19 $236.18 2025-02-06 $188.14 +6.4% 74% A
J.P. Morgan Securities
US Large Cap
REITERATE BUY $228.17 $220.17 2025-01-29 $192.14 +4.2% 67% B
Bernstein Autonomous
Forensic Coverage
INITIATE HOLD $204.15 — 2025-01-17 $196.15 +2.0% 61% B
Barclays Capital
Americas Research
DOWNGRADE UNDERPERFORM $176.13 $190.14 2025-01-09 $178.13 -11.2% 42% D
UBS Investment Bank
Institutional Desk
UPGRADE BUY $238.18 $208.16 2024-12-18 $174.13 +14.9% 72% A
Citigroup Global Markets
Sector Lead
TARGET REV HOLD $194.15 $202.15 2024-12-04 $186.14 -4.3% 48% C